Systematic characterization of tandem repeat variants contributing to complex traits

导致复杂性状的串联重复变异的系统表征

基本信息

  • 批准号:
    10052847
  • 负责人:
  • 金额:
    $ 70.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-17 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

SUMMARY ABSTRACT Genome-wide association studies (GWAS) have identified thousands of genetic loci associated with complex traits, but determining the causal variants, target genes, and biological mechanisms responsible for each signal has proven challenging. Furthermore, standard GWAS based on single nucleotide polymorphisms (SNPs) have been limited by failure to explain the majority of heritability for most traits studied and an inability to capture multi-allelic variants such as copy number variants (CNVs) and repeats not tagged by SNPs. We focus on the role of genetic variation at repetitive regions of the genome. Specifically, we consider two repeat types: short tandem repeats (STRs), consisting of repeated motifs of 1-6bp; and variable number tandem repeats (VNTRs), with motifs of 7+bp. We collectively refer to STRs and VNTRs as tandem repeats (TRs). TRs encompass approximately 2 million loci comprising over 3% of the genome. They exhibit rapid mutation rates and are one of the largest sources of genetic variation. Growing evidence suggests that TRs are likely to account for part of the “missing heritability” of GWAS. However, due to bioinformatic and experimental challenges in studying repeats, the genome-wide role of TRs in human traits remains mostly unexplored. We hypothesize that TR variants are key drivers of complex traits. We recently identified thousands of STRs predicted to causally regulate gene expression (termed expression STRs, or eSTRs) and revealed that eSTRs potentially act through a variety of mechanisms including modulating nucleosome positioning and DNA or RNA secondary structure. We additionally identified specific eSTRs likely underlying published GWAS signals for height and schizophrenia. Furthermore, other groups have recently discovered TRs as causal drivers of complex traits including malaria resistance, cancer risk, and bipolar disorder. While these findings offer intriguing evidence that thousands of TRs contribute to human phenotypes, they have several limitations. These include: the range of TRs that can be accurately genotyped from next- generation sequencing (NGS); a lack of sufficiently large NGS datasets for most traits for performing association analyses; and limited understanding of the potential mechanisms by which TRs participate in gene regulation. Here, we leverage (i) our recently developed TR genotyping tools and (ii) our published haplotype panel allowing imputation of TRs into available SNP-array datasets, to systematically evaluate the contribution of TRs to gene regulation and complex traits in humans. We will first generate a comprehensive catalog of TRs associated with gene regulation (Aim 1) and establish a framework for validating TR effects using massively parallel reporter assays and genome editing (Aim 2). We will then impute more than 2 million TRs into large existing GWAS datasets and perform fine-mapping to identify TRs associated with a range of complex traits and deeply characterize several TRs predicted to be causal drivers of GWAS signals (Aim 3). This project will fill an important gap in our knowledge of the genetic architecture of complex traits.
摘要摘要 全基因组关联研究(GWAS)已经确定了数千个与 复杂的特征,但确定了负责的因果变异,靶基因和生物学机制 每个信号都有经过证明的挑战。此外,基于单个核苷酸多态性的标准GWA (SNP)受到未能解释大多数特征的遗传力的限制,并且无法解释 捕获多相关变体,例如拷贝数变体(CNV),并重复SNP标记。 我们关注遗传变异在基因组重复区域的作用。具体来说,我们考虑 两种重复类型:短串联重复序(STR),由1-6bp的重复基序组成;和变量数 串联重复(VNTR),基序为7+bp。我们共同将Strs和VNTR称为串联重复 (TR)。 TRS包括大约200万个基因座,占基因组的3%以上。他们表现出迅速的表现 突变率,是遗传变异的最大来源之一。越来越多的证据表明TR是 可能是GWAS的“缺失遗传力”的一部分。但是,由于生物信息学和实验性 在研究重复方面的挑战,TR在人类特征中的全基因组作用仍然大多是出乎意料的。 我们假设TR变体是复杂性状的关键驱动力。我们最近确定了数千个 预测的因果体调节基因表达(称为表达strs或Entrs)的StR,并揭示了这一点 ESTR可能通过多种机制作用,包括调节核小体定位和DNA 或RNA二级结构。我们还确定了可能出版的GWAS信号潜在的特定偏心 高度和精神分裂症。此外,其他团体最近发现TRS是 复杂性状,包括疟疾抗性,癌症风险和躁郁症。 尽管这些发现提供了有趣的证据,表明成千上万的TR有助于人类表型,但 他们有几个局限性。其中包括:可以从下一 生成测序(NGS);对于大多数特征,缺乏足够大的NGS数据集用于执行关联 分析;对TRS参与基因调节的潜在机制的了解有限。 在这里,我们利用(i)我们最近开发的TR基因分型工具,以及(ii)我们已发布的单倍型面板允许 将TRS插入可用的SNP阵列数据集中,以系统地评估TRS对基因的贡献 人类的调节和复杂特征。我们将首先生成与与之相关的TRS的全面目录 基因调节(AIM 1)并建立一个框架,用于使用大量平行报告基因验证TR效应 测定和基因组编辑(AIM 2)。然后,我们将将超过200万TR算成大型现有GWAS 数据集并执行精细映射以识别与一系列复杂性状相关的TR和深层 描述几个被预测为GWAS信号的因果驱动因素(AIM 3)。这个项目将填补 我们对复杂性状遗传结构的了解的重要差距。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Alon Goren的其他基金

Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism
基于 SETD5 的新型分子机制和治疗工具来理解和恢复与智力障碍和自闭症相关的神经元功能障碍
  • 批准号:
    10446957
    10446957
  • 财政年份:
    2022
  • 资助金额:
    $ 70.5万
    $ 70.5万
  • 项目类别:
Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism
基于 SETD5 的新型分子机制和治疗工具来理解和恢复与智力障碍和自闭症相关的神经元功能障碍
  • 批准号:
    10585929
    10585929
  • 财政年份:
    2022
  • 资助金额:
    $ 70.5万
    $ 70.5万
  • 项目类别:
Systematic characterization of tandem repeat variants contributing to complex traits
导致复杂性状的串联重复变异的系统表征
  • 批准号:
    10671075
    10671075
  • 财政年份:
    2020
  • 资助金额:
    $ 70.5万
    $ 70.5万
  • 项目类别:
Systematic characterization of tandem repeat variants contributing to complex traits
导致复杂性状的串联重复变异的系统表征
  • 批准号:
    10265508
    10265508
  • 财政年份:
    2020
  • 资助金额:
    $ 70.5万
    $ 70.5万
  • 项目类别:
Systematic characterization of tandem repeat variants contributing to complex traits
导致复杂性状的串联重复变异的系统表征
  • 批准号:
    10459499
    10459499
  • 财政年份:
    2020
  • 资助金额:
    $ 70.5万
    $ 70.5万
  • 项目类别:
Development of a novel method to chart genomic localization of protein complexes in vivo
开发一种绘制蛋白质复合物体内基因组定位图的新方法
  • 批准号:
    9511383
    9511383
  • 财政年份:
    2018
  • 资助金额:
    $ 70.5万
    $ 70.5万
  • 项目类别:
Interrogating regulatory variants by multiplexed genome editing
通过多重基因组编辑询问调控变异
  • 批准号:
    9761568
    9761568
  • 财政年份:
    2018
  • 资助金额:
    $ 70.5万
    $ 70.5万
  • 项目类别:

相似国自然基金

2023年(第四届)国际生物数学与医学应用研讨会
  • 批准号:
    12342004
  • 批准年份:
    2023
  • 资助金额:
    8.00 万元
  • 项目类别:
    专项项目
突变和修饰重塑蛋白质亚细胞定位的生物信息学研究
  • 批准号:
    32370698
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于生物信息学的类风湿性关节炎患者衰弱预测模型的构建与验证
  • 批准号:
    82301786
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于结构表征的蛋白质与长链非编码RNA相互作用预测的生物信息学方法研究
  • 批准号:
    62373216
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
蛋白质降解决定因子的生物信息学筛选及其耐药突变的多组学分析研究
  • 批准号:
    32300528
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Genetic Architecture of Aging-Related TDP-43 and Mixed Pathology Dementia
衰老相关 TDP-43 和混合病理痴呆的遗传结构
  • 批准号:
    10658215
    10658215
  • 财政年份:
    2023
  • 资助金额:
    $ 70.5万
    $ 70.5万
  • 项目类别:
Transposable Elements at the Crossroads of Evolution, Health and Disease
处于进化、健康和疾病十字路口的转座元件
  • 批准号:
    10750852
    10750852
  • 财政年份:
    2023
  • 资助金额:
    $ 70.5万
    $ 70.5万
  • 项目类别:
“Pharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment response”
– NR4A1 和 NR4A2 的药理学靶向激活胶质母细胞瘤治疗反应 –
  • 批准号:
    10744524
    10744524
  • 财政年份:
    2023
  • 资助金额:
    $ 70.5万
    $ 70.5万
  • 项目类别:
Dissecting the tumor cell-immune TME axis to identify therapeutically actionable vulnerabilities that potentiate immunotherapy in GBM
剖析肿瘤细胞免疫 TME 轴,以确定可增强 GBM 免疫治疗的治疗上可操作的漏洞
  • 批准号:
    10743534
    10743534
  • 财政年份:
    2023
  • 资助金额:
    $ 70.5万
    $ 70.5万
  • 项目类别:
Molecular Immunology Core
分子免疫学核心
  • 批准号:
    10622125
    10622125
  • 财政年份:
    2023
  • 资助金额:
    $ 70.5万
    $ 70.5万
  • 项目类别: